Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 49
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 63
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: BioSig Technologies, Inc. - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

BioSig Technologies Inc. (BSGM)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: BioSig Technologies, Inc. - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCC)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 51
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Cyclacel Pharmaceuticals, Inc. - Common Stock.

Comment Full text

DURECT Corporation (DRRX)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 67
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: DURECT Corporation - Common Stock.

Comment Full text

Cyclacel Pharmaceuticals Inc. (CYCCP)

  • Technical Exchange News
  • Sept. 12, 2025, 07:32 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock. New value: Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock.

Comment Full text

Protagenic Therapeutics Inc. (PTIXW)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 57
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Protagenic Therapeutics Inc. (PTIX)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

PLURI (PLUR)

  • Technical Exchange News
  • Sept. 12, 2025, 01:38 UTC
  • 56
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 421
  • 422
  • 423
  • 424
  • 425
  • Next

Search

News categories

  • Technical Exchange News(14235)
  • Event(6229)
  • SEC News(366957)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(225322)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin